Related Experiment Video
Updated: May 1, 2026

10:47
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
15.7K
Designing a broad-spectrum multi-epitope subunit vaccine against leptospirosis using immunoinformatics and structural
Guneswar Sethi1,2, Young Kyu Kim1, Su-Cheol Han2
1Animal Model Research Group, Korea Institute of Toxicology, Jeonguep, Jeollabuk-do, Republic of Korea.
Frontiers in Immunology
|February 12, 2025
Summary
A novel multi-epitope subunit vaccine (MESV) shows promise for preventing leptospirosis. This computational study designed a vaccine targeting Leptospira, demonstrating broad population coverage and strong immune responses.
Area of Science:
- Immunology
- Vaccinology
- Computational Biology
Background:
- Leptospirosis, caused by Leptospira interrogans, is a neglected zoonotic disease with global health implications.
- Antimicrobial resistance and vaccine inefficacy necessitate novel preventive strategies for leptospirosis.
Purpose of the Study:
- To design a broad-spectrum multi-epitope subunit vaccine (MESV) against leptospirosis using an immunoinformatics approach.
- To computationally evaluate the vaccine's physicochemical properties, structural integrity, and potential immunogenicity.
Main Methods:
- Selected B-cell, CTL, and HTL epitopes from key Leptospira proteins.
- Constructed MESV with HBHA adjuvant and linkers, assessed properties, modeled 3D structure.
- Performed molecular docking, MD simulations, MM-GBSA, immune simulations, and in silico cloning.
Main Results:
- MESV exhibited high antigenicity, immunogenicity, non-allergenicity, and conservation.
- T-cell epitopes showed significant HLA interactions, covering 95.7% of the global population.
- Strong binding to TLR2/TLR4 confirmed, with robust B and T cell responses predicted.
Conclusions:
- The designed MESV is a promising candidate for leptospirosis prevention due to its broad coverage and predicted efficacy.
- Further in vivo studies are required to validate the vaccine's efficacy and safety in preclinical models.
Keywords:
immunoinformaticsin silico cloningleptospirosismolecular dockingmolecular dynamics simulationmulti-epitope subunit vaccinepopulation coverage
